GW0742 % In Stock PPAR agonist -

GW0742 % In Stock PPAR agonist - gw0742 GW0742 rescued the overweight and the glucose tolerance, tackled hepatic inflammation and favored hepatic beta-oxidation over lipogenesis These gw0742 GW0742 is the first VDR ligand inhibitor lacking the secosteroid structure of VDR ligand antagonists Nevertheless, the VDR-meditated downstream

gw0742 GW0742 docking conformation compared to the GW0742 of the crystal structure 3D detail of the amino acids forming polar bindings with GW0742

gw0742 GW0742 is known to be an activator of PPAR-δ,19 and it can increase the expression of PPAR-δ 20 Therefore, GW0742 is widely used as an agonist Biochemphysiol Actions GW0742 is a highly selective PPARδ agonist EC50 = 1 nM vs 1 μM and 2 μM for PPARα and PPARγ, respectively